Retraction notice to ” Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol” (Fertility and Sterility (2009) 91(3) (838–841), (S0015028208000101), (10.1016/j.fertnstert.2008.01.016));Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol

Fertility and Sterility

Volumn 91, Issue 3, 2009, Pages 838-841

  Badawy, Ahmed ^a   Inany, Hesham ^b   Mosbah, Abeer ^a   Abulatta, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

clomiphene citrate; Ovulation induction; polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EARLY INTERVENTION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL BLEEDING;

EID: 61349127966     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2023.06.020     Document Type: Erratum

References (8)

1. Homburg R. Clomiphene citrate: end of an era? A mini-review. Hum Reprod 20 (2005) 2043-2051
2. Bilijan M.M., Mahutte N.G., Tuland T., and Tan S.L. Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end organs. Fertil Steril 71 (1999) 633-638
3. Chung H., and Craig A.W. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 52 (1989) 564-568
4. Dehbashi S., Vafaei H., Parsanezhad M.D., and Alborzi S. Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome. Intern J Gynecol Obstet 93 (2006) 44-48
5. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
6. Horstein M.D., and Schust D. Infertility. In: Berek J.S. (Ed). Novak's gynecology (1996), Lippincott Williams & Wilkins, Philadelphia 973-1066
7. Speroff L., Glass R.H., and Kase N.G. Ovulation induction. In: Speroff L., Glass R.H., and Kase N.G. (Eds). Clinical gynecologic endocrinology and infertility. 6th ed. (1999), Lippincott Williams & Wilkins, Baltimore 1097-1133
8. Marrs R.P., Vargyas J.M., Shanold G.M., and Yee B. The effect of time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures. Fertil Steril 41 (1984) 682-685